296. Biliary atresia
53 clinical trials,   56 drugs   (DrugBank: 31 drugs),   43 drug target genes,   50 drug target pathways
Searched query = "Biliary atresia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00166868 (ClinicalTrials.gov) | December 2003 | 12/9/2005 | Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy | Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia | Biliary Atresia | Drug: Lactobacillus casei rhamnosus (Lcr35);Drug: Neomycin | National Taiwan University Hospital | NULL | Completed | 4 Months | 3 Years | Both | 30 | N/A | Taiwan |